Steven H. Collis - 09 Nov 2021 Form 4 Insider Report for AMERISOURCEBERGEN CORP (COR)

Role
Chairman, President & CEO, Director
Signature
/s/ John G. Chou, attorney-in-fact for Steven H. Collis
Issuer symbol
COR
Transactions as of
09 Nov 2021
Net transactions value
-$1,612,115
Form type
4
Filing time
12 Nov 2021, 15:42:44 UTC
Previous filing
14 Oct 2021
Next filing
15 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABC Common Stock Options Exercise $1,255,900 +12,784 +6.9% $98.24 197,363 09 Nov 2021 Direct
transaction ABC Common Stock Options Exercise $868,003 +11,480 +5.8% $75.61 208,843 09 Nov 2021 Direct
transaction ABC Common Stock Sale $3,041,007 -24,264 -12% $125.33 184,579 09 Nov 2021 Direct
transaction ABC Common Stock Options Exercise +12,718 +6.9% 197,297 10 Nov 2021 Direct F1
transaction ABC Common Stock Tax liability $695,010 -5,530 -2.8% $125.68 191,767 10 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABC Non-qualified Stock Option (Right to Buy) Options Exercise $0 -11,480 -6.2% $0.000000 172,200 09 Nov 2021 Common Stock 11,480 $75.61 Direct F2, F3
transaction ABC Non-qualified Stock Option (Right to Buy) Options Exercise $0 -12,784 -25% $0.000000 38,351 09 Nov 2021 Common Stock 12,784 $98.24 Direct F4
transaction ABC Restricted Stock Units Options Exercise $0 -12,718 -33% $0.000000 25,437 10 Nov 2021 Common Stock 12,718 $0.000000 Direct F1
transaction ABC Restricted Stock Units Award +35,806 35,806 10 Nov 2021 Common Stock 35,806 $0.000000 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2021, 11/10/2022, and 11/10/2023.
F2 The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective 8/20/21 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on 8/26/21.
F3 Exercisable in four equal annual installments on 11/9/17, 11/9/18, 11/9/19 and 11/9/20.
F4 Exerciseable in four equal annual installments on 11/11/16, 11/11/17, 11/11/18 and 11/11/19.
F5 Grant of restricted stock units received for no consideration that vest in three equal annual installments on 11/10/2022, 11/10/2023, and 11/10/2024.